• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Emergent BioSolutions

J&J must reportedly throw out 60M COVID-19 vaccine doses from Emergent plant

June 11, 2021 By Sean Whooley

Another large amount of doses of Johnson & Johnson’s COVID-19 vaccine produced at an embattled manufacturing plant reportedly have to be thrown out. The New York Times reported that the FDA told J&J that about 60 million doses of the single-dose vaccine produced at Emergent BioSolutions’ Baltimore plant can’t be used because of possible contamination. Get the full […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Food & Drug Administration (FDA), Pharmaceutical, Recalls, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Emergent BioSolutions, FDA, Johnson & Johnson

DeviceTalks Weekly Podcast – iRhythm CEO Mike Coyle, New Podcast!

April 23, 2021 By Tom Salemi

In this podcast, iRhythm CEO Mike Coyle discusses his decision to join the digital health leader in January. Coyle’s had to hit the ground running as iRhythm manages some challenging decisions from regional Medicare payors, but he also sees great opportunity for the company’s Zio platform across the healthcare spectrum. In this conversation, Coyle discusses […]

Filed Under: Cardiovascular, Device Talks Podcasts, Digital Health, Featured, Special Content Tagged With: DeviceTalks Weekly, Emergent BioSolutions, Intuitive Surgical, iRhythm Technologies Inc., Medtronic, NeuroPace, Stryker, Zimmer Biomet

FDA releases scathing inspection report regarding Emergent BioSolutions plant

April 21, 2021 By Brian Buntz

An FDA report cites multiple failures in an Emergent BioSolutions plant tapped to produce vaccines for Johnson & Johnson and AstraZeneca. The vaccine plant had been forced to discard up to 15 million doses of Johnson & Johnson’s COVID-19 vaccine in a single manufacturing batch. Emergent Biosolutions recently paused production of the vaccine during the FDA inspection and […]

Filed Under: Featured, Pharmaceutical Tagged With: AstraZeneca, AstraZeneca plc, coronavirus, COVID-19 vaccine, COVID-19 vaccines, Emergent BioSolutions, FDA, Johnson and Johnson

Emergent has reportedly had serious problems at Baltimore vaccine plant

April 6, 2021 By Chris Newmarker

Emergent BioSolutions was not prepared to take on the mammoth task of churning out millions of COVID-19 vaccine doses to support U.S. efforts to end the pandemic, according to a report published today in The New York Times. Emergent was ill-equipped despite a $163 million federal contract to prepare the facility for high-volume production, according to the Times investigation, […]

Filed Under: Contract Manufacturing, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, COVID-19 vaccine, Emergent BioSolutions, Johnson & Johnson

Feds put J&J in charge of vaccine production at Emergent plant

April 5, 2021 By Sean Whooley

Johnson & Johnson (NYSE:JNJ) announced that it assumed full responsibility for the production of its COVID-19 vaccine at the Emergent BioSolutions Bayview (Baltimore) facility. The company’s announcement comes days after news broke that a factory error made at that facility resulted in 15 million discarded COVID-19 vaccines. Get the full story at our sister site, […]

Filed Under: Contract Manufacturing, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Emergent BioSolutions, FDA, Johnson & Johnson

Amid controversy, Biden cancels Emergent Biosolutions visit 

March 10, 2021 By Brian Buntz

The White House scrapped plans to hold a meeting today at a Baltimore-based vaccine plant run by Emergent BioSolutions following an exposé from The New York Times.   The Biden administration also announced plans to conduct an audit of the Strategic National Stockpile after the publication of the article, which described how the biopharmaceutical company lobbied […]

Filed Under: Business/Financial News, Featured Tagged With: anthrax, anthrax vaccine, AstraZeneca, Emergent BioSolutions, Joe Biden, Strategic National Stockpile, White House

How Johnson & Johnson is expanding manufacturing for a potential coronavirus vaccine

April 27, 2020 By Sean Whooley

Johnson & Johnson (NYSE:JNJ) recently announced that its Janssen Pharmaceutical Cos. will collaborate with Emergent BioSolutions to support the manufacturing of its lead investigational COVID-19 vaccine candidate. The New Brunswick, N.J.–based pharmaceutical and medical device giant described the deal as the first in a series of contract manufacturing agreements that it expects to ink as it seeks […]

Filed Under: Contract Manufacturing, Pharmaceutical Tagged With: coronavirus, COVID-19, Emergent BioSolutions, Johnson and Johnson

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS